Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma for moderate to severe COVID-19 pneumonia
MOH_2020-06-14_009029Phase 4Not yet recruiting
- Sponsor
- ד"ר יסמין מאור
- Start
- May 2020
- Countries
- 1
01
Overview
Phase 4, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by ד"ר יסמין מאור. Planned start May 2020; status: not yet recruiting.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on MOH_2020-06-14_009029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-06-14_009029.